Drug profile · INN
glucagon
BAQSIMI
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
glucagon (BAQSIMI) is an FDA-listed pharmaceutical active ingredient. Associated with Amphastar France Pharmaceuticals. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN glucagon
Brand BAQSIMI
Route INTRAVENOUS
Formulation INJECTABLE
ATC code H04AA01
Originator Amphastar France Pharmaceuticals
Frequently asked questions
What is glucagon?
glucagon (BAQSIMI) is an FDA-listed pharmaceutical active ingredient. Associated with Amphastar France Pharmaceuticals. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for glucagon?
BAQSIMI is a marketed brand name for glucagon. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of glucagon?
glucagon has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.